Collaborations & Alliances

Thermo Fisher, SRI in Small Molecule Research Alliance

New link combining metabolic pathway and genome data aims to speed data analysis for compound discovery

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific and SRI International have entered a collaboration agreement to allow researchers to combine the results of high-resolution Orbitrap LC/MS experiments with organism-specific metabolic pathway and genome data for quicker and more effective mass spectrometry-based small molecule research and analysis. Researchers will now have a direct link between the Thermo Scientific Compound Discoverer 2.1 software platform and SRI’s BioCyc, a collection of 9,300 databases that prov...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters